Furthermore, a majority of them did not clearly converge on the functional categories consistent with known aspects of T2D pathophysiology, i.e., impaired insulin secretion and insulin resistance in peripheral tissues—the two hallmark glycemic intermediate traits of T2D. The gene discussed is INS; the disease is Insulin resistance.